5 Lung Cancer Treatments Helping Mesothelioma Patients

Treatment & Doctors
Reading Time: 3 mins
Publication Date: 11/21/2017
Fact Checked
Our fact-checking process begins with a thorough review of all sources to ensure they are high quality. Then we cross-check the facts with original medical or scientific reports published by those sources, or we validate the facts with reputable news organizations, medical and scientific experts and other health experts. Each page includes all sources for full transparency.
Reviewed

Asbestos.com is the nation’s most trusted mesothelioma resource

The Mesothelioma Center at Asbestos.com has provided patients and their loved ones the most updated and reliable information on mesothelioma and asbestos exposure since 2006.

Our team of Patient Advocates includes a medical doctor, a registered nurse, health services administrators, veterans, VA-accredited Claims Agents, an oncology patient navigator and hospice care expert. Their combined expertise means we help any mesothelioma patient or loved one through every step of their cancer journey.

More than 30 contributors, including mesothelioma doctors, survivors, health care professionals and other experts, have peer-reviewed our website and written unique research-driven articles to ensure you get the highest-quality medical and health information.

About The Mesothelioma Center at Asbestos.com

  • Assisting mesothelioma patients and their loved ones since 2006.
  • Helps more than 50% of mesothelioma patients diagnosed annually in the U.S.
  • A+ rating from the Better Business Bureau.
  • 5-star reviewed mesothelioma and support organization.
Learn More About Us

Testimonials

"My family has only the highest compliment for the assistance and support that we received from The Mesothelioma Center. This is a staff of compassionate and knowledgeable individuals who respect what your family is experiencing and who go the extra mile to make an unfortunate diagnosis less stressful. Information and assistance were provided by The Mesothelioma Center at no cost to our family."
Lashawn
Mesothelioma patient’s daughter
  • Google Review Rating
  • BBB Review Rating

How to Cite Asbestos.com’s Article

APA

Povtak, T. (2020, October 16). 5 Lung Cancer Treatments Helping Mesothelioma Patients. Asbestos.com. Retrieved October 6, 2022, from https://www.asbestos.com/blog/2017/11/21/lung-cancer-drugs-mesothelioma/

MLA

Povtak, Tim. "5 Lung Cancer Treatments Helping Mesothelioma Patients." Asbestos.com, 16 Oct 2020, https://www.asbestos.com/blog/2017/11/21/lung-cancer-drugs-mesothelioma/.

Chicago

Povtak, Tim. "5 Lung Cancer Treatments Helping Mesothelioma Patients." Asbestos.com. Last modified October 16, 2020. https://www.asbestos.com/blog/2017/11/21/lung-cancer-drugs-mesothelioma/.

There still is no definitive cure for pleural mesothelioma, but patients today are living longer and better lives, thanks in part to recent treatment advances surrounding lung cancer.

The diseases may be different, but some of the therapies have become easily transferable. Mesothelioma patients and families should take note.

A patient with a rare cancer such as mesothelioma can benefit from research of a more common type such as lung cancer.

The attention to Lung Cancer Awareness Month throughout November — and the millions of dollars in research funding it generates — also can be beneficial to future mesothelioma patients.

The broad, multidisciplinary approach to both cancers still includes surgery, chemotherapy and radiation, but there is much more available with today’s personalized treatment approach.

Don’t Wait for the FDA

The U.S. Food and Drug Administration (FDA) has not changed its only approved treatment of unresectable mesothelioma — a cisplatin and pemetrexed chemotherapy regimen — since 2004, but there is no need to wait for the government agency to act.

Look to lung cancer, and ask your mesothelioma specialist what might fit for your individual situation, either through a clinical trial or through the FDA’s Expanded Access (Compassionate Use) program.

Immunotherapy Leading the Way

Most of the new therapies will come under the broad heading of immunotherapy, which helps a patient’s immune system fight the cancer. Other emerging treatments include a vaccine and a form of T cell therapy.

Pembrolizumab (Keytruda)

The FDA recently approved pembrolizumab, also known by the brand name Keytruda, as a first-line use for non-small cell lung cancer in combination with chemotherapy.

It previously was approved for use as a single agent, but only for patients with the expression of a protein called PD-L1. In one recent study, the drug demonstrated double the effectiveness of the chemotherapy being used.

Pembrolizumab is being studied now for a wide variety of cancers in more than 400 clinical trials, including 10 for mesothelioma. Mesothelioma survivor Walter Merth of Philadelphia believes the drug has allowed him to continue living a relatively normal life.

Nivolumab (Opdivo)

This was the first single-agent immunotherapy drug approved (in 2015) for non-small cell lung cancer as a second-line treatment. It also was approved by the FDA in 2014 for use in combination with Yervoy, a skin cancer drug.

Mesothelioma survivor Gene Hartline of Lady Lake, Florida, credits Opdivo (nivolumab) for fighting off his cancer and extending his life considerably.

“The way I feel now, I could live another 20 years,” said Hartline, now 77.

Atezolizumab (Tecentriq)

Drug manufacturer Genentech is hoping atezolizumab — manufactured under the brand name Tecentriq — can follow the path of Keytruda and Opdivo as the latest immunotherapy drug working its way through the clinical trial process.

Tecentriq received FDA approval in 2016 for certain types of bladder cancer. It also has received approval for second-line treatment in non-small cell lung cancer where chemotherapy has stopped working.

CimaVax Vaccine

Clinical trials have begun recently in the U.S. for this vaccine that was first developed in Cuba to combat lung cancer.

CimaVax works by attacking the epidermal growth factor that is often overexpressed in lung cancer patients. The recent loosening of the 54-year-old embargo of Cuban products made it more accessible. It is being explored today for use with a number of cancers.

CAR T Cell Therapy

Chimeric antigen receptor (CAR) T cell therapy is the latest approach to cancer therapy and proven effective with blood cancers.

It involves a laboratory reprograming of a patient’s own white blood cells, helping them attack the cancer more effectively. It is a form of customized gene therapy.

The FDA recently approved CAR T cell therapy for pediatric leukemia, and it has shown considerable promise already with some forms of lung cancer in clinical trials.

Medically Reviewed by Top Mesothelioma Doctors
Free Mesothelioma Guide